Karin holds a PhD in Medical Science with focus on Immunology. Her academic work also includes studies of DNA vaccines and virus genetics. With an interest and experience in method development and quality assurance Karin excels at well-performed analysis. Having worked with development of routine diagnostics, large and small molecule pharmaceuticals and with patent strategies she understands the importance of high quality knowledge at every decision point. Karin has worked as lab director at Statens Serum Institut in Denmark, project manager in biotech companies, IP manager at Alligator Bioscience AB, as CEO of ProNoxis AB and is the co-owner of Avena Partners AB. Karin is driven by her curiosity and thrive for development.